The Federal Floor: 40 CFR Part 433 Pretreatment for Pharmaceutical Plants
40 CFR Part 433 is the categorical pretreatment standard that binds any pharmaceutical manufacturer discharging process wastewater to a POTW in the United States, regardless of ownership. The rule sits below the state-level TPDES permit but above local limits, and it sets effluent ceilings that the new operator must meet on day one of Merck ownership, before any Texas-specific transfer paperwork is filed. An acquired plant inherits its compliance posture: ownership change is not a defense under the Clean Water Act, and the local POTW's EPA-approved pretreatment program is the day-to-day enforcement authority (per 40 CFR 403, with program approval administered by TCEQ in Texas).
Part 433 contains four subcategories, and the one that applies depends on what the plant actually makes. A Merck-acquired API or fermentation plant falls into Subpart C (Organic Chemicals Manufacturing), while a formulation, packaging, or secondary dosage-form facility with only incidental synthesis is more likely to be classified Subpart D (Bulk Pharmaceutical Manufacturing). The buyer's environmental team should request the seller's existing POTW industrial user permit and the most recent categorical monitoring report to confirm the subcategory before closing.
The four core regulated parameters and their categorical limits are summarized below. A buyer who sees a Total Toxic Organics (TTO) daily maximum above 2.13 mg/L in the seller's DMRs is looking at an open pretreatment violation that will become Merck's exposure on the closing date.
| Parameter | Categorical Daily Maximum | Categorical Monthly Average | Source |
|---|---|---|---|
| BOD₅ | 267 mg/L | 117 mg/L | 40 CFR 433.12(a) |
| TSS | 117 mg/L | 49 mg/L | 40 CFR 433.12(a) |
| pH | 6.0–9.0 standard units at all times | 40 CFR 433.12(b) | |
| Oil & Grease | 38 mg/L | 22 mg/L | 40 CFR 433.12(c) |
| Total Toxic Organics (TTO) | 2.13 mg/L | — | 40 CFR 433.12(e) |
The 2006 Merck Upper Gwynedd release of a toxic chemical to the township WWTP is the documented precedent for what happens when a pharmaceutical discharger ignores its categorical pretreatment obligations. The takeaway for any deal team: confirm the target's TTO and metals data, not just BOD and TSS, before signing.
TPDES Permit Transfer or Re-Coverage: The 30-Day TCEQ Clock
TPDES (Texas Pollutant Discharge Elimination System) is the Texas-implemented version of the federal NPDES program, authorized by TCEQ under Texas Water Code Chapter 26 and 30 TAC Chapter 305. Any industrial wastewater discharge in Texas requires either an individual TPDES permit or coverage under a general permit, and that authorization is issued to a specific permittee. 30 TAC §305.64 requires the new owner to file a written notification of the ownership change with TCEQ within 30 days of the closing date. Miss that window and the seller remains the permittee of record while the new operator runs the plant without an authorization, which is the type of fact pattern that produces a Notice of Violation on day 31.
What the buyer actually submits depends on what the target currently holds. Three outcomes cover the realistic cases. First, if the change is a name change inside the same legal entity, TCEQ processes an administrative permit amendment with no change to permit conditions. Second, if the target holds an individual TPDES industrial wastewater permit, the buyer files a full permit transfer application and TCEQ re-issues the permit in the new operator's name with the same effluent limits, monitoring frequencies, and compliance schedule. Third, if the target qualifies for the multi-sector general permit TXR050000, the new operator files a new Notice of Intent (NOI) for coverage under the new ownership.
The TCEQ transfer submission is standardized: Form 20049 (Core Data Form) capturing the new operator's regulated entity and customer reference numbers, a signed transfer application, the existing permit number, the proposed effective date, and a demonstration that the new operator has the technical and financial capacity to comply. TCEQ will review the existing DMRs and the seller's enforcement record to evaluate the new operator's ability to comply, and a pattern of late reports or exceedances can be used to slow or condition the transfer. Until TCEQ processes the transfer, the seller remains the permittee of record and is liable for any discharge violations, even after closing — a sequencing risk the purchase agreement must address with escrow, a specific indemnity, or a pre-closing consent order. Engineers evaluating pretreatment upgrades during diligence can review the pharma wastewater DAF vs clarifier comparison for the unit-operation envelope a 40 CFR 433-compliant plant typically operates within.
PUC Approval Under Texas Water Code §13.301 — Only If a CCN Is Involved

A Certificate of Convenience and Necessity (CCN) is a PUC-issued authorization to provide water or sewer utility service within a defined service area in Texas. A typical pharmaceutical manufacturing plant does not hold a CCN; it treats and disposes of its own process wastewater on-site under a TPDES permit and discharges to a municipal POTW under a private industrial user agreement. PUC approval under §13.301 is in scope only when the target's asset bundle includes a regulated water or sewer utility that serves outside customers, such as a plant-owned wastewater treatment works that also accepts haul waste or serves a co-located industrial park.
If a CCN is in the deal, Texas Water Code §13.301 sets a sequencing rule: on or before the 120th day before the effective date of the sale, acquisition, lease, or rental, the parties must file a written application with the PUC and issue notice of the application, unless the PUC waives notice. That 120-day clock runs backwards from the closing date, so the LOI stage is when the buyer must confirm whether a CCN exists and whether the closing date is feasible. In practice, the closing date is set backwards from a target PUC sign-off date.
The PUC's substantive review focuses on whether the buyer has the financial, managerial, and technical capability to provide continuous and adequate service. If the PUC is not satisfied, it can require the buyer to post a bond or other financial assurance in a form and amount the PUC specifies — a cost item that should be modeled in the purchase price. Customers in the CCN service area are entitled to notice of the application and can protest, which is the most common source of delay. For facilities that do not hold a CCN, this section is informational only and the deal team can move directly to the TPDES sequencing.
Sequencing the Permits: A Day-Counted Timeline From LOI to Day 30 Post-Closing
The single most common mistake in Texas plant acquisitions is treating the TPDES and PUC filings as post-closing housekeeping. The 120-day PUC clock (if a CCN is involved) and the 30-day TCEQ clock run from the closing date, and a plant cannot legally operate under a new owner with the prior operator's permit in the interim period. The table below is the day-counted sequence the deal team should hand to outside counsel and the integration PMO.
| Day-Count Milestone | Action | Authority / Form |
|---|---|---|
| LOI to T-150 | Confirm whether target holds a CCN; pull existing TPDES permit number and most recent DMRs | Diligence (internal) |
| T-120 | If a CCN is in the deal, file PUC §13.301 written application and issue customer notice | PUC / Texas Water Code §13.301 |
| T-90 | Negotiate TCEQ permit-transfer consent order language; finalize Form 20049 and transfer application package | TCEQ / 30 TAC §305.64 |
| T-30 to T-0 | Risk window: seller is still the TPDES permittee of record; any pre-closing spill or sampling anomaly is seller's exposure and buyer's negotiation leverage | Contractual (escrow / indemnity) |
| T-0 (Closing) | File TCEQ permit transfer or new NOI under TXR050000; effective date equals closing date | TCEQ / 30 TAC §305.64 |
| T+30 | File post-closing POTW industrial user permit re-application in new operator's name | Local POTW / 40 CFR 403 |
| T+30 | File EPA TRI Form R under new facility ID if SIC 2833/2834 thresholds under EPCRA §313 are triggered | EPA / EPCRA §313 |
| T+60 | Re-evaluate EPA Risk Management Program (40 CFR Part 68) trigger from listed chemicals above threshold quantities and update RMP if needed | EPA / 40 CFR Part 68 |
Two items in the table are commonly missed because they are not strictly wastewater. First, the EPA Risk Management Program (40 CFR Part 68) — if the target stores any of 140 listed chemicals above threshold quantities, the new operator must re-evaluate the RMP within 60 days of acquisition. Second, the EPA Toxics Release Inventory (TRI) Form R under EPCRA §313 — the SIC codes 2833 (Medicinals and Botanicals) and 2834 (Pharmaceutical Preparations) trigger TRI reporting for facilities that manufacture or process more than 25,000 lb or otherwise use more than 10,000 lb of any listed TRI chemical per year, and a new operator must file under the new facility ID within 30 days. The 2026 SK On Texas plant acquisition guide walks the same sequencing logic for a battery-chemicals target and is a useful cross-reference for the team: SK On Texas plant wastewater acquisition guide.
Environmental Due Diligence: The Five Documents That Must Be Pulled Before Signing

The week-one data room request should include these five documents for every pharmaceutical target, regardless of size. They are: (1) the current TPDES permit and the most recent 12 months of Discharge Monitoring Reports; (2) the POTW industrial user permit and any pretreatment audit findings or compliance letters; (3) the ASTM E1527-21 Phase I Environmental Site Assessment and any Phase II subsurface investigations; (4) TRI Form R submissions for the last three years; and (5) any open TCEQ Notices of Violation, consent orders, or Agreed Orders. A pharma wastewater process and compliance guide is also a useful sanity check for whether the target's process flow is consistent with its reported effluent.
One item is often missed and is a closing condition rather than a request: an ASTM E1527-21 Phase I completed more than 180 days before closing must be updated before the buyer can rely on it for the CERCLA §101(35) innocent landowner defense. Under CERCLA §101(35) and §107, a buyer who knew or should have known of a release at closing is an "owner" for liability purposes, and the Phase I update protects the buyer from that successor-liability exposure. For the integration phase, a DAF system is a common upgrade path when the Phase I or DMR review surfaces oil and grease or TSS excursions, and a chlorine dioxide disinfection system is often the unit operation used to address residual disinfection compliance in the TPDES-permitted outfall.
Frequently Asked Questions
What is a TPDES permit and when is one required?
A TPDES permit is the Texas Pollutant Discharge Elimination System authorization issued by TCEQ under Texas Water Code Chapter 26 and 30 TAC Chapter 305, implementing the federal NPDES program in Texas. Any point-source discharge of process wastewater, stormwater associated with industrial activity, or treated domestic wastewater to waters of
Frequently Asked Questions
What permits need to be transferred when Merck buys a Texas pharmaceutical plant?
Merck must transfer the Texas Pollutant Discharge Elimination System (TPDES) permit, which governs the discharge of treated wastewater into state waters. Additionally, if the facility manages hazardous waste, the Texas Commission on Environmental Quality (TCEQ) requires the transfer of the Industrial and Hazardous Waste (IHW) permit, as well as any existing air quality permits issued under 30 TAC Chapter 116.
How long does TCEQ take to approve a wastewater permit transfer after acquisition?
Under 30 TAC Section 305.64, the TCEQ typically processes an ownership transfer application within 30 to 60 days, provided the application is administratively complete. However, if the transfer involves a major permit amendment or a significant change in the nature of the facility's operations, the review period may extend to 90 days or longer due to mandatory public notice requirements.
Does 40 CFR Part 433 apply to all pharmaceutical manufacturing facilities?
No, 40 CFR Part 433 applies specifically to the Metal Finishing Point Source Category, which regulates wastewater discharges from processes such as electroplating, coating, and chemical etching. Pharmaceutical manufacturing facilities are primarily governed by 40 CFR Part 439, which establishes effluent limitations guidelines based on the specific type of pharmaceutical product (e.g., fermentation, extraction, or chemical synthesis) being produced.
Who is liable for environmental violations at a Texas plant after it is sold?
Liability for environmental violations typically transfers to the new owner upon the effective date of the acquisition, as stipulated in the TPDES permit transfer agreement. While specific indemnification clauses in the purchase agreement may allocate financial responsibility for pre-existing conditions between Merck and the seller, the TCEQ and the EPA hold the current permit holder legally responsible for ongoing compliance and reporting obligations.
What is the difference between a TPDES individual permit and the TXR050000 multi-sector general permit?
A TPDES individual permit is a site-specific authorization tailored to the unique wastewater characteristics and flow volumes of a specific pharmaceutical plant, often including numeric effluent limitations for specific pollutants. In contrast, the TXR050000 Multi-Sector General Permit (MSGP) is designed for industrial stormwater discharges and requires adherence to a standardized Stormwater Pollution Prevention Plan (SWPPP) rather than specific process wastewater discharge limits.